Maryam Oskoui
Investigator
Pediatric Neurologist, Neurophysiologist and Epidemiologist, Montreal Children’s Hospital
Professor, Departments of Pediatrics and Neurology and Neurosurgery, McGill University | Scientist, Research Institute of the McGill University Health Centre
NMD4C Involvement: Pillar 2: Clinical Research
Email MaryamBiography
Dr. Maryam Oskoui is a pediatric neurologist, neurophysiologist and epidemiologist. She is a Distinguished Clinical Research Scholar of the Fonds de Recherche Quebec with a focus in clinical research and clinical trials in pediatric neuromuscular disorders and has contributed to over 100 peer reviewed publications. She is a Principal investigator and SMA lead for INFORM RARE, a Strategy for Patient Oriented Research innovative clinical trial initiative supported by CIHR.
Dr. Oskoui serves as an evidence-based methodologist for the American Academy of Neurology and has contributed to numerous clinical care guidelines. She contributes to the Canadian Neuromuscular community by serving as a member of the Scientific Advisory Committee for Muscular Dystrophy Canada and is past chair of the Canadian Pediatric Neuromuscular Group and the Canadian Neuromuscular Disease Registry’s Spinal Muscular Atrophy Working Group. She is a Board member for the Association des Neurologues du Quebec
Dr. Oskoui completed her medical school and pediatric neurology residency at McGill University (Montreal, Canada), neuromuscular clinical and research fellowship at Columbia University (New York, USA) and Master’s of Science in Clinical Epidemiology at McGill University.
Recent Publications
Lochmüller, H, Gonorazky, H, Nigro, E, Mah, JK, Alemán, A, Yaworski, A et al.. Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy. J Neurol. 2026.273 (3) PMID:41774261
Servais, L, Oskoui, M. Broad lessons from negative trials in rare diseases. Lancet Neurol. 2026.25 (3)215-217 PMID:41722576
Piché, JV, Hussein, N, Kirton, A, Fehlings, D, Oskoui, M, Shevell, M et al.. Characteristics of unilateral cerebral palsy according to gestational age at birth: A retrospective study. Dev Med Child Neurol. 2026. PMID:41670174
Kwon, JM, Munell, F, Le Goff, L, Yuge, K, Kato, T, Cances, C et al.. Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. Nat Med. 2026.32 (2)763 PMID:41606122
Socha, PM, Oskoui, M, Hutcheon, JA, Harper, S. A multivariable model for improving the identification of cerebral palsy cases in administrative health data. Ann Epidemiol. 2026.114 26-31 PMID:41539408
See more on PubMed